Notably, the number of cybersecurity-related patent applications in the medical industry was 253 in Q1 2023, versus 329 in the prior quarter.
The top five companies accounted for 19% of patenting activity
Analysis of patenting activity by companies shows that Abbott Laboratories filed the most cybersecurity patents within the medical industry in Q1 2023. The company filed 22 cybersecurity-related patents in the quarter, compared with 2 in the previous quarter. It was followed by Johnson & Johnson with 11 cybersecurity patent filings, Becton Dickinson and Co (6 filings), and DexCom (5 filings) in Q1 2023.
Patenting activity was driven by China with a 26% share of total patent filings
The largest share of cybersecurity related patent filings in the medical industry in Q1 2023 was in China with 26%, followed by the US (10%) and South Korea (7%). The share represented by China was 0.45% lower than the 26% share it accounted for in Q4 2022.
To further understand GlobalData’s analysis on Cybersecurity in Healthcare – Thematic Research buy the report here.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
